T1	Participants 53 84	arterial hypertensive patients.
T2	Participants 161 280	49 hypertensive patients (WHO I-II), divided into three parallel randomized groups, were studied over a 6 months period
T3	Participants 474 537	Patients were instructed to maintain their usual dietary habits
T4	Participants 623 998	In the clopamide monotherapy group, total cholesterol increased significantly (p less than 0.05); triglycerides and LDL showed a tendency to increase while for HDL a tendency to decrease was observed. In the pindolol monotherapy group, a significant reduction of triglycerides (p less than 0.01) and a significant increase of HDL cholesterol (p less than 0.05) were recorded.
T5	Participants 1615 1673	hypertensive subjects with metabolic coronary risk factors
